Drug details
Rasuvo (methotrexate non-pyrogenic solution for a single subcutaneous injection)
type of DMARDs, Immunomodulators, Antineoplastics, Antimetabolite
Rasuvo (methotrexate) is a folate analog metabolic inhibitor used to manage severe, active rheumatoid arthritis (RA) (ACR criteria) in adults, or active polyarticular juvenile idiopathic arthritis (pJIA) in children, who have had an insufficient response to, or are intolerant of, nonsteroidal anti-inflammatory drugs (NSAIDs). Rasuvo is also used in adults for symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy.
The drug is often used to treat Arthritis , Psoriasis .
This drug may have the following side effects:
- nausea,
- headache,
- dizziness,
- vomiting,
- indigestion,
- diarrhea,
- skin rash,
- abdominal pain,
- fever,
- runny or stuffy nose,
- easy bruising or bleeding,
- temporary hair loss, or
- blurred vision.
- difficulty swallowing,
- trouble breathing,
- stomach pain or discomfort,
- mouth blisters or sores,
- red or swollen gums,
- sun sensitivity,
- a burning sensation of psoriasis lesions,
- abnormal liver function tests,
The following drugs are related to Rasuvo, either as a replacement or used together:
- Humira (adalimumab injection solution for subcutaneous administration)
- Kineret (anakinra)
- Imuran (azathioprine)
- Olumiant (baricitinib tablets)
- Bextra (valdecoxib)
- Wynzora (calcipotriene and betamethasone dipropionate cream)
- Celebrex (celecoxib)
- Cimzia (certolizumab pegol injection)
- Clinoril (sulindac)
- Cortaren (dexamethasone sodium phosphate injection)
- Emerphed (ephedrine sulfate injection)
- Remicade (infliximab)
- Trexall (methotrexate)
- RediTrex (methotrexate injection)
- Xatmep (methotrexate oral solution)
- Xeljanz (tofacitinib tablets)